Drug intelligence / Profile preview

acetaminophen + caffeine

Development stage
Unknown
Lead developer
CRIS Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Acetaminophen + Caffeine (also known as paracetamol with caffeine) is an approved oral small molecule combination drug used for the relief of mild to moderate pain. The combination consists of **acetaminophen**, a non-opioid analgesic and antipyretic, and **caffeine**, a methylxanthine that acts as a central nervous system stimulant and analgesic adjuvant. Acetaminophen primarily works by inhibiting prostaglandin synthesis in the central nervous system, thereby reducing pain and fever. Caffeine acts as an adenosine receptor antagonist; in this combination, it enhances the analgesic efficacy of acetaminophen and may accelerate its onset of action by modulating pain perception and improving drug absorption. It is commonly indicated for conditions such as tension headaches, migraines, musculoskeletal pain, and general aches.

Brand names
Panadol ExtraSolpadeine HeadacheHedex ExtraExcedrin Tension Headache
Other names
paracetamol + caffeineacetaminophen and caffeineParacetamol with Caffeine Tablets
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)

Beyond the preview

Go deeper on acetaminophen + caffeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + caffeine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call